Low‐dose naltrexone: a novel treatment for Hailey–Hailey disease. (1st May 2018)

• Record Type: Journal Article
• Authors: Campbell, V.; McGrath, C.; Corry, A.
• Is Part Of: British journal of dermatology. Volume 178:Number 5(2018)
• Page Start: 1196
• Page End: 1198
• Publication Date: 2018-05-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.16045
• Languages: English
• ISSNs: 0007-0963

Abstract

Summary: Hailey–Hailey disease (chronic benign familial pemphigus) is a rare inherited dermatosis typically characterized by erosions at intertriginous sites preceded by minor trauma or stress. We report a case of treatment‐resistant Hailey–Hailey disease having failed topical and oral steroids, prophylactic aciclovir and doxycycline, and systemic therapies including dapsone, acitretin and ciclosporin. Low‐dose naltrexone 4·5 mg once daily was commenced following an incidental benefit in this patient's similarly affected sister. The clinical and psychological response to date has been considerable.